1. ScholarBank@NUS

Koh, S.C.L.

rp01431

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Koh, S.C.L.
Variants
Koh, S.C.L.
Kohsc, L.
Kohcl, S.
Koh, C.L.S.
Koh, C.S.
Koh, S.C.
Koh, S.
 
Faculty
 
Email
obgkohcl@nus.edu.sg
 

Publications

Results 1-20 of 57 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
12006A prognosis tool based on hemostasis and genetic complementary learningTan, T.Z.; Ng, G.S.; Quek, C.; Koh, S.C.L. 
21999A prospective study on the effects of reformulated 2-rod Norplant implant on haemostasis after five years of useKoh, S.C.L. ; Viegas, O.A.C. ; Ratnam, S.S. 
31995Amniotic fluid plasminogen activators and inhibitors and TAT-complex levels during 2nd trimester pregnancy and labourKoh, S.C.L. ; Anandakumar, C. ; Arulkumaran, S. ; Chua, S.E.; Yuen, W.K.; Ng, B.L. ; Ratnam, S.S. 
42000An assessment of the effects on coagulation of midtrimester and final- trimester amniotic fluid on whole blood by thrombelastograph® analysisLiu, E.H.C. ; Shailaja, S.; Lee, T.-L. ; Koh, S.C.L. 
52005An intelligent tutoring system for trauma management (Trauma-Teach): A preliminary reportOng, L.S. ; Koh, C.S. ; Lai, C.C.; Lim, C.W. ; Loke, W.F.; Low, S.H. ; Tang, K.Y.; Wong, F.L.; Yong, K.L.; Vijayan, A.
62007Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancerZhao, C.; Annamalai, L. ; Koh, S.C.L. ; Zhang, H.; Biswas, A. ; Choolani, M. ; Guo, C.; Kothandaraman, N. 
7Nov-1997Coagulation Activation, Fibrinolysis and Inhibitors in NeonatesKoh, S.C.L. ; Cheong, Y.C.; Arulkumaran, S. ; Ratnam, S.S. 
82005Coagulation and fibrinolysis in preeclampsia and neonatesTanjung, M.T.; Siddik, H.D.; Hariman, H.; Koh, S.C.L. 
91999Coagulation and fibrinolysis in viable mid-trimester pregnancies of normal, intrauterine growth retardation, chromosomal anomalies and hydrops fetalis and their eventual obstetric outcomeKoh, S.C.L. ; Anandakumar, C. ; Biswas, A. 
101990Comparative study on the effect of Diane and Microgynon 50 contraceptive in the haemostatic mechanisms in Chinese subjectsKoh, S.C.L. ; Ratnam, S.S. ; Tsakok, F.H.M.
111992Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycleKoh, S.C.L. ; Wong, P.C.; Yuen, R.; Chua, S.E.; Ng, B.L.; Ratnam, S.S. 
122004Early detection of epithelial ovarian cancer using a proteomics-based protein-profiling approach combined with a novel selection strategy.Kothandaraman, N.; Bajic, V.B.; Loganath, A. ; Koh, S. ; Ng, J.; Choolani, M. ; Razvi, K.
131992Effect of long-term use of Norplant® implants on haemostatic functionSingh, K. ; Viegas, O.A.C. ; Koh, S.C.L. ; Ratnam, S.S. 
141992Effect of Norplant®-2 rods on haemostatic functionSingh, K. ; Viegas, O.A.C. ; Koh, C.L.S. ; Ratnam, S.S. 
151989Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet functionPrasad, R.N.V. ; Koh, S. ; Ratnam, S.S. 
16Jan-1999Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrelPrasad, R.N.V. ; Koh, S.C.L. ; Viegas, O.A.C.; Ratnam, S.S. 
172000Enhanced fibrinolysis and thrombin generation in ovarian cancer patients with than without metastasisKohcl, S. ; Thamk, F. ; Khalil, R. ; Oep, L.; Lim, F.K. ; Chua, S.E.; Yuen, W.K.; Ng, B.L.; Roy, A.C. ; Prasad, R.N.V. 
182001Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?Koh, S.C.L. ; Tham, K.-F. ; Razvi, K. ; Oei, P.-L. ; Lim, F.-K. ; Roy, A.-C. ; Prasad, R.N.V. 
192001Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?Koh, S.C.L. ; Tham, K.-F. ; Razvi, K.; Oei, P.-L. ; Lim, F.-K. ; Roy, A.-C. ; Prasad, R.N.V. 
202005Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycleKoh, S.C.L. ; Prasad, R.N.V. ; Fong, Y.F.